Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Heterozygous p.Asp50Asn mutation in the GJB2 gene in two Cameroonian patients with keratitis-ichthyosis-deafness (KID) syndrome

  • Ambroise Wonkam1, 2, 3Email author,
  • Jean Jacques N Noubiap2,
  • Jason Bosch1,
  • Collet Dandara1 and
  • Geneviève Bengono Toure2
BMC Medical Genetics201314:81

https://doi.org/10.1186/1471-2350-14-81

Received: 21 February 2013

Accepted: 7 August 2013

Published: 7 August 2013

Abstract

Background

Keratitis-Ichthyosis-Deafness (KID) syndrome (OMIM 148210) is a congenital ectodermal defect that consists of an atypical ichthyosiform erythroderma associated with congenital sensorineural deafness. KID appears to be genetically heterogeneous and most cases are caused by GJB2 mutations. Mutations in African patients have been rarely described.

Case presentation

We report on two unrelated Cameroonian individuals affected with sporadic KID, presenting with the classic phenotypic triad. The two patients were heterozygous for the most frequent p.Asp50Asn mutation. This first report in patients from sub-Saharan African origin supports the hypothesis that the occurrence of KID due to p.Asp50Asn mutation in GJB2 seems not to be population specific.

Conclusions

Our finding has implication in medical genetic practice, specifically in the molecular diagnosis of KID in Africans. These cases also reveal and emphasize the urgent need to develop appropriate policies to care for patients with rare/orphan diseases in Sub-Saharan Africa, as many of these cases become more and more recognizable.

Keywords

KID syndrome GJB2 gene p.Asp50Asn mutation Africa Cameroon

Background

The Keratitis-ichthyosis-deafness (KID) syndrome (OMIM 148210 and 242150) is a rare congenital ectodermal disorder of unknown prevalence. Approximately 100 cases have been reported in the world to date [1]. KID appears to be genetically heterogeneous and most cases are caused by mutations in the connexin 26 gene, GJB2. Connexins are membrane proteins with a common structure consisting of four transmembrane domains linked by one cytoplasmic and two extracellular loops (namely, EC1, and EC2, respectively), with both cytoplasmic N-terminal and C-terminal [2]. Different mutations in the genes encoding connexins can disturb the gap junction system of one or several ectodermal epithelia, which in the case in KID syndrome, where the epidermis, the inner ear and the corneal epithelium are affected [3].

Skinner et al. reviewed 18 affected patients and proposed the acronym ‘KID syndrome’ to describe three main symptoms, ichthyosis, vascularizing keratitis, and often profound sensorineural hearing loss [4]. KID is genetically heterogeneous and is caused by missense mutations in the connexin (CX) genes GJB2 and GJB6, which cluster at chromosome 13q11-q12 and encode the closely related gap junction β-2 protein (coded by CX26) and β-6 protein (coded by CX30) [5, 6]. Inheritance of KID syndrome is usually sporadic but autosomal recessive and dominant cases have been reported [5].

Mutations in cases of KID syndrome have been rarely reported in patients of African descent [7], but p.Asp50Asn mutation in the GJB2 gene have been previously only reported in a black patient from the Emirates [8]. In this article, we report on two unrelated Cameroonian patients with KID syndrome presenting with heterozygous p.Asp50Asn mutation in the GJB2 gene.

Case presentation

Patients and methods

We previously published on aetiological factors of congenital hearing loss on 582 Cameroonians [9]. Amongst them, two young patients presented with clinical features of KID syndrome.

DNA amplification and mutation analysis

Genomic DNA samples were extracted from peripheral blood of the two patients, using Puregene blood Kit® (Qiagen, USA), following the manufacturer’s protocol and this was carried out in the Molecular Diagnosis Laboratory of the Gyneco-Obstetric and Paediatric Hospital of Yaoundé, Cameroon. The GJB2 gene was amplified following the method of Liu et al. [10]. Exon 2 was amplified and then sequenced using an ABI 3130XL Genetic Analyze® automated sequencer (Applied Biosystems, USA), in the Molecular Research laboratory in the Division of Human Genetics, University of Cape Town, South Africa.

Clinical data

Patient 1

A five-year-old girl that presented with a profound bilateral sensorineural deafness diagnosed at 2 years old. She was born at term to unrelated healthy parents after an uneventful pregnancy and normal vaginal delivery, and presented at birth with generalized erythema. She had a history of chronic otitis externa and hypohidrosis. Her psychomotor development was normal; however, physical examination revealed a generalized thickened skin and xeroderma, palmoplantar keratoderma and rippled hyperkeratotic plaques on the knees and elbows (Figure 1A-D). She had aged facial appearance, hypotrichosis (sparse of eyelashes and eyebrows), and hyperkeratosis lesions in the external auditory canal. Ophthalmologic examination revealed a mild vascularizing keratitis which explained her photophobia and reduced visual acuity. Oral examination showed dental dysplasia and histopathological examination of the skin revealed an acanthotic dyskeratosis. The parents were non-consanguineous and there was no family history of similar condition.
Figure 1

Illustrations of some clinical features of the two Cameroonian KID cases (Case 1; panels A-D; Case 2 panels E and F). A) Keratoderma of the soles B) Rippled hyperkeratotic plaques on the knees; C) Hypotrichosis of the eyelashes and eyebrows; D) Mild vascularizing keratitis; E) Hyperkeratosis of the hands; F) Alopecia, hypotrichosis, ichthyosiform erythrokeratoderma.

Patient 2

A two-year-old girl that presented with a prelingual bilateral profound sensorineural deafness. She was born at term after an uncomplicated pregnancy and delivery. Since two months of age, she presented with thick, reddened patches of the skin that were dry and scaly. The thickness of the skin gradually increased as she grew older. At the time of presentation at the health facility physical examination revealed generalized ichthyosiform erythrokeratoderma, palmoplantar keratoderma, alopecia universalis and atrichosis (absence of eyelashes and eyebrows) (Figure 1E-F). Joint mobility of the elbows, knees and ankles was seriously reduced by keratoderma. She had photophobia and ocular irritation, and an ophthalmologic examination revealed a vascularizing keratitis. The intraoral examination was normal. She had no major neurological abnormalities and her non-consanguineous parents and young sister were all healthy and there was no family history of similar clinical presentation.

On familial history, the two patients were unrelated: their parents originated from, and live in, two geographically distinct of area of Cameroon (Western and Centre provinces, about 400 km apart). The parents belonged to two different ethno-linguistic groups: Bantu and Nilo-Sahelian, respectively.

Genetic analysis

Analysis of GJB2 exon 2 in the genomic DNA of the two unrelated patients revealed a heterozygous missense mutation c.148G > A, resulting in a putative amino acid change from aspartic acid (GAC) to asparagine (AAC) in codon 50 p.Asp50Asn (Figure 2). p.Asp50Asn were not present in more than 180 unrelated individuals who were screened for recessive deafness mutations or in 60 healthy control persons of Cameroonian origin [unpublished results].
Figure 2

Mutation analysis of GJB2 in the two Cameroonian individuals affected with sporadic KID. Panel A: Sequence chromatograms of GJB2 from unaffected individual; Panel B: Sequence chromatograms from affected patients depicting the heterozygous transition 148G → A at codon 50 encoding asparagine instead of aspartic acid (p.Asp50Asn) (Panel B).

Moreover, sequences data from both patients did not show any other common changes, but the p.Asp50Asn variant. The DNA sequence in patient 1 did not have any other changes than the p.Asp50Asn variant, while patient 2 was also heterozygote for the most common non pathogenic polymorphism, g.3318-34C > T. Thus, there was no further need to compare the haplotypes from the two patients to establish unrelatedness.

Discussion

To the best of our knowledge, this is the first report of sub-Saharan African patients with KID syndrome due to the p.Asp50Asn mutation in GJB2.

GJB2 mutations responsible for non-syndromic hearing loss have been reported in many parts of the world with marked variations in distribution patterns among different ethnic groups, with a propensity to occur frequently in some population groups (in Europe, North America and Asia) [10, 11], while seemingly absent in African populations [12]. Contrary to GJB2 mutations causing autosomal recessive non-syndromic hearing loss (HL) which are ethnically specific because of founder effect in some specific populations, GJB2 mutations responsible for syndromic hearing loss seem not to be population specific [5].

The two patients reported here presented with the classic phenotypic triad of KID syndrome including diffuse hyperkeratotic erythroderma, vascularizing keratitis, and profound bilateral sensorineural hearing loss. Several other features were associated including alopecia, hypotrichosis and hypohydrosis, porokeratotic eccrine ostial and dermal duct nevus, follicular occlusion triad and dental anomalies previously [13, 14]. Moreover, the p.Asp50Asn mutation has also been reported in KID patients with Dandy-Walker malformation [15]; although brain imaging was not performed, the two cases described here did not have neurologic features that would suggest the occurrence of Dandy-Walker malformation. The p.Asp50Asn mutation has been reported mostly in sporadic cases, but also in a case of autosomal dominant inheritance [5]. In a cohort of 14 patients affected with KID syndrome originating from 11 families, where parent to child transmission in families was verified by molecular analysis, twelve patients (86%) were heterozygous for the p.Asp50Asn mutation. The disease was sporadic in 64%, whereas 36% was familial, suggestive of autosomal dominant inheritance with one parent clinically affected in all the families. A family with p.Asp50Asn mutation was suggestive of germinal mosaicism, as the parent was clinically normal [16]. Similar report of germinal mosaicism was also reported in family with dizygotic twins suffering from a lethal form of KID; the two patients were heterozygous for the p.G45E mutation of GJB2, whereas the mutation was not detected in the two parents [7]. The two pairs of Cameroonian parents did not consent for their molecular analysis, claiming in both cases, that this will not have any implication in improving the care of their KID-affected children. However, since none of the parents were clinically affected, and in absence of reported proven familial case with reduce penetrance, mutations in these two Cameroonian cases are most likely de novo.

p.Asp50Asn appears to be the most prevalent mutation in unrelated KID patients of Caucasian ancestry [5, 16], and the two unrelated Cameroonian cases provide additional information that this mutation may also be important in African populations. The amino acid replacement, in p.Asp50Asn mutation, occurs in the highly conserved first extracellular loop of CX26, which is crucial for voltage gating and connexon-connexon interactions [2, 17]. The majority of dominantly-acting connexin mutations, associated with autosomal dominant syndromic HL are situated in this domain and are missense mutations, while the majority that cause recessive HL are nonsense mutations or small deletions [17]. Moreover, it has been observed that alteration of calcium ion fluxes due to the effects of mutations such as p.Asp50Asn, result in cell death by necrosis [18]. In addition, other functional analyses showed that p.Asp50Asn have consequences for protein localization and gap junction permeability [19]. However, more evidences are needed to associate the variable phenotypes observed in KID with effects on protein trafficking or gap junction permeability.

The management of KID syndrome in Cameroon as in other low-income countries is a critical issue. The most beneficial treatment for the profound hearing impairment in our patients could be cochlear implantation [20], a procedure that is unavailable in Cameroon. There is no universal medical insurance in Cameroon and even hearing aids are not affordable for most patients. Keratitis (also observed in the two cases) can result in progressive decline of visual acuity and may eventually lead to blindness which combined with a profound hearing loss constitute a disastrous disability. In addition, a life-long follow-up of these patients is necessary because the KID syndrome is associated with malignant tumours, particularly squamous cell carcinoma [1]. Although the provision of service for medical care for KID patients is limited in Cameroon, better awareness of the disease within the region would help patients if upon diagnosis, better prevention of the worst effects of disease can be instituted, which besides follow-up for cancerous lesions, would include simple preventative measures against fatal septicemia from recurrent skin infections; specifically for the keratitis; there is a need to develop an appropriate specialist services in the country that could help to prevent blindness.

Conclusion

In conclusion, our report supports the occurrence of KID due to p.Asp50Asn mutations in GJB2 in Africans and seems to indicate that this mutation is not ethically specific. These cases reveal and emphasize the urgent need to develop appropriate policies to care for patients with rare/orphan diseases in Sub-Saharan Africa, as many of these cases become more and more recognizable.

Consent

The study was performed in accordance with the guidelines of the Helsinki Declaration and was approved by the National Ethics Committee of Cameroon (ethics approval N°123/CNE/SE/2010), and the Faculty of Health Sciences Research Ethics Committee, University of Cape Town, HREC REF: 080/2011. Written informed consents were obtained from patient parents for publication and the accompanying images. Copies of the written consents are available for review.

Abbreviations

KID: 

Keratitis-ichthyosis-deafness

EC1 and EC2: 

Extracellular loops 1 and 2

CX: 

Connexion.

Declarations

Acknowledgements

We are grateful to the patients and their parents for their participation in this research. This research was funded by the National Health Laboratory Services (NHLS), South Africa, which provided financial support for material and reagents to perform the molecular analysis.

Authors’ Affiliations

(1)
Division of Human Genetics, Department of Clinical Laboratory Sciences, Faculty of Health Sciences, University of Cape Town
(2)
Faculty of Medicine and Biomedical Sciences, University of Yaoundé I
(3)
Division of Human Genetics, Faculty of Health Sciences, University of Cape Town

References

  1. Genetics Home Reference, Keratitis-ichthyosis-deafness syndrome. (Reviewed November 2012): http://ghr.nlm.nih.gov/condition/keratitis-ichthyosis-deafness-syndrome,
  2. Evans WH, Martin PE: Gap junctions: structure and function. Mol Membr Biol. 2002, 19: 121-136. 10.1080/09687680210139839.View ArticlePubMedGoogle Scholar
  3. Pfenniger A, Wohlwend A, Kwak BR: Mutations in connexin genes and disease. Eur J Clin Invest. 2011, 41: 103-116. 10.1111/j.1365-2362.2010.02378.x.View ArticlePubMedGoogle Scholar
  4. Skinner BA, Greist MC, Norins AL: The keratitis, ichthyosis, and deafness (KID) syndrome. Arch Dermatol. 1981, 117: 285-289. 10.1001/archderm.1981.01650050041019.View ArticlePubMedGoogle Scholar
  5. Richard G, Rouan F, Willoughby CE, Brown N, Chung P, Ryynänen M, Jabs EW, Bale SJ, DiGiovanna JJ, Uitto J, Russell L: Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome. Am J Hum Genet. 2002, 70: 1341-1348. 10.1086/339986.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Jan AY, Amin S, Ratajczak P, Richard G, Sybert VP: Genetic heterogeneity of KID syndrome: identification of a CX30 Gene (GJB6) mutation in a patient with KID syndrome and congenital atrichia. J Invest Dermatol. 2004, 122: 1108-1113. 10.1111/j.0022-202X.2004.22518.x.View ArticlePubMedGoogle Scholar
  7. Jonard L, Feldmann D, Parsy C, Freitag S, Sinico M, Koval C, Grati M, Couderc R, Denoyelle F, Bodemer C, Marlin S, Hadj-Rabia S: A familial case of keratitis-ichthyosis-deafness (KID) syndrome with the GJB2 mutation G45E. Eur J Med Genet. 2008, 51: 35-43. 10.1016/j.ejmg.2007.09.005.View ArticlePubMedGoogle Scholar
  8. Maintz L, Betz RC, Allam JP, Wenzel J, Jaksche A, Friedrichs N, Bieber T, Novak N: Keratitis-ichthyosis-deafness syndrome in association with follicular occlusion triad. Eur J Dermatol. 2005, 15: 347-352.PubMedGoogle Scholar
  9. Wonkam A, Noubiap JJ, Djomou F, Fieggen K, Njock R, Toure GB: Etiology of childhood hearing loss in Cameroon (sub-Saharan Africa). Eur J Med Genet. 2013, 56: 20-25. 10.1016/j.ejmg.2012.09.010.View ArticlePubMedGoogle Scholar
  10. Liu XZ, Xia XJ, Ke XM, Ouyang XM, Du LL, Liu YH, Angeli S, Telischi FF, Nance WE, Balkany T, Xu LR: The prevalence of connexin 26 (GJB2) mutations in the Chinese population. Hum Genet. 2002, 111: 394-397. 10.1007/s00439-002-0811-6.View ArticlePubMedGoogle Scholar
  11. Pandya A, Arnos KS, Xia XJ, Welch KO, Blanton SH, Friedman TB, Garcia Sanchez G, Liu MDXZ, Morell R, Nance WE: Frequency and distribution of GJB2 (connexin 26) and GJB6 (connexin 30) mutations in a large North American repository of deaf probands. Genet Med. 2003, 5: 295-303. 10.1097/01.GIM.0000078026.01140.68.View ArticlePubMedGoogle Scholar
  12. Kabahuma RI, Ouyang X, Du LL, Yan D, Hutchin T, Ramsay M, Penn C, Liu XZ: Absence of GJB2 gene mutations, the GJB6 deletion (GJB6-D13S1830) and four common mitochondrial mutations in nonsyndromic genetic hearing loss in a South African population. Int J Pediatr Otorhinolaryngol. 2011, 75: 611-617. 10.1016/j.ijporl.2011.01.029.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Richard G: Connexin disorders of the skin. Clin Dermatol. 2005, 23: 23-32.View ArticlePubMedGoogle Scholar
  14. Lazic T, Li Q, Frank M, Uitto J, Zhou LH: Extending the phenotypic spectrum of keratitis-ichthyosis-deafness syndrome: report of a patient with GJB2 (G12R) Connexin 26 mutation and unusual clinical findings. Pediatr Dermatol. 2012, 29: 349-357. 10.1111/j.1525-1470.2011.01425.x.View ArticlePubMedGoogle Scholar
  15. Todt I, Mazereeuw-Hautier J, Binder B, Willems PJ: Dandy-Walker malformation in patients with KID syndrome associated with a heterozygote mutation (p.Asp50Asn) in the GJB2 gene encoding connexin 26. Clin Genet. 2009, 76: 404-408. 10.1111/j.1399-0004.2009.01211.x.View ArticlePubMedGoogle Scholar
  16. Mazereeuw-Hautier J, Bitoun E, Chevrant-Breton J, Man SY, Bodemer C, Prins C, Antille C, Saurat JH, Atherton D, Harper JI, Kelsell DP, Hovnanian A: Keratitis-ichthyosis-deafness syndrome: disease expression and spectrum of connexin 26 (GJB2) mutations in 14 patients. Br J Dermatol. 2007, 156: 1015-1019. 10.1111/j.1365-2133.2007.07806.x.View ArticlePubMedGoogle Scholar
  17. Iossa S, Marciano E, Franzé A: GJB2 gene mutations in syndromic skin disorders with sensorineural hearing loss. Curr Genomics. 2011, 12: 475-785. 10.2174/138920211797904098.View ArticlePubMedPubMed CentralGoogle Scholar
  18. Zong WX, Thompson CB: Necrotic death as a cell fate. Genes Dev. 2006, 20: 1-15. 10.1101/gad.1376506.View ArticlePubMedGoogle Scholar
  19. de Zwart-Storm EA, Rosa RF, Martin PE, Foelster-Holst R, Frank J, Bau AE, Zen PR, Graziadio C, Paskulin GA, Kamps MA, van Geel M, van Steensel MA: Molecular analysis of connexin26 asparagine14 mutations associated with syndromic skin phenotypes. Exp Dermatol. 2011, 20: 408-412. 10.1111/j.1600-0625.2010.01222.x.View ArticlePubMedGoogle Scholar
  20. Barker EJ, Briggs RJ: Cochlear implantation in children with keratitis-ichthyosis-deafness (KID) syndrome: outcomes in three cases. Cochlear Implants Int. 2009, 10: 166-173. 10.1002/cii.374.View ArticlePubMedGoogle Scholar
  21. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2350/14/81/prepub

Copyright

© Wonkam et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.